Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
Cover Story

Migraine and CVD: A call for greater awareness

Drug Risk Update A companion database for use with

Raymond L. Woosley, MD, PhD; Klaus Romero, MD; C. Will Heise, MD; Tyler Gallo, PharmD; R. David Woosley, MPH

FDA News

FDA advisory committees back CV safety of celecoxib

FDA panel supports approval of volanesorsen for familial chylomicronemia syndrome

Antidote for certain direct oral anticoagulants receives FDA approval

In the Journals

Disparities in CVD burden persist among US states

Dual antithrombotic therapy safer than triple therapy in AF after PCI

Moderate to vigorous physical activity benefits reflex control of BP during pregnancy

FDA analysis: Women underrepresented in HF, CAD, ACS trials

Ambulatory BP measurements strong predictors of mortality

High-intensity statin therapy less likely in women after MI

High-sensitivity troponin T levels detect low-risk patients

CMS to cover MRIs for patients with pacemakers, ICDs

Meeting News

Outcomes worse with delayed discharge after transfemoral TAVR

PROGRESS CTO registry highlights feasibility of hybrid approach at experienced centers

US ranking for heart transplant candidates may prompt overtreatment

At Issue: CABANA sparks debate over appropriateness of ablation in AF

HRS: How to counsel patients on cardiac device cybersecurity

CABANA: Ablation an ‘acceptable treatment strategy’ for AF

CV risk increases with hormone therapy in transgender patients

Botulinum toxin suppression of AF maintained at 3 years

Alternative antibiotic strategy modestly improves cardiac device infection rate

Next Gen Innovators

Cardiology Today honors Next Gen Innovators at ACC 2018

Trial Scorecards

Trial Scorecard: CABANA

Trial Scorecard: KP-RHYTHM

Trial Scorecard: TASMINH4

Trial Scorecard: NAVIGATE ESUS

Trial Scorecard: FIX-HF-5C

Trial Scorecard: PADIT

Trial Scorecard: PROGRESS CTO

Trial Scorecard: POINT